These data, together with bioinformatics and structural modeling studies [40,78,79,80,81,82], provide a basis for understanding the details of the molecular mechanisms by which pathogenic GJB2 variants lead to different clinical hearing loss phenotypes. Here, GJB2 is linked to hearing loss disorder.